NLRP3 and Cognitive impairment: Administration of NLRP3 or caspase-1 inhibitors resulted in a significant increase of microglia ability to clear Aβ deposits, as well as in reduced Aβ deposition and improvement in cognitive impairment and hyperactive behavior [128,129].